Filter
212
Filtered Results: 212
Text search:
counterfeit
drug
Featured
Recommendations
14
New Publications
65
Language
Document type
No document type
107
Studies & Reports
46
Guidelines
31
Manuals
11
Strategic & Response Plan
8
Training Material
3
Situation Updates
3
Fact sheets
3
Countries / Regions
Kenya
12
Uganda
11
Nigeria
8
Ghana
7
Tanzania
7
Ethiopia
7
Zimbabwe
5
Cambodia
5
Liberia
5
Sierra Leone
4
Malawi
4
Global
4
Botswana
4
Zambia
4
Myanmar / Burma
4
Rwanda
3
South–East Asia Region
3
Bangladesh
3
South Africa
3
Eswatini/ Swaziland
3
Nepal
2
Ukraine
2
Cameroon
2
Senegal
2
Philippines
2
Africa
2
Latin America and the Carribbean
2
Namibia
2
Thailand
1
Lesotho
1
China
1
Laos
1
Burkina Faso
1
Mozambique
1
Haiti
1
Asia
1
Congo, Democratic Republic of
1
North America
1
Vietnam
1
Moldova
1
Sri Lanka
1
Central African Republic
1
Indonesia
1
Somalia
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
102
Public Health
11
Clinical Guidelines
7
Pharmacy & Technologies
6
Key Resources
5
Women & Child Health
2
Toolboxes
Pharmacy
35
AMR
32
Malaria
8
Mental Health
6
TB
5
HIV
4
Global Health Education
4
Rapid Response
3
COVID-19
3
NTDs
3
Conflict
3
Caregiver
2
Planetary Health
2
Specific Hazards
1
Natural Hazards
1
Disability
1
Ebola & Marburg
1
Social Ethics
1
NCDs
1
Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo.
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
PMPB/INS-GUIDE/04
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The classification of digital health interventions (DHIs) categorizes the different ways in which digital and mobile technologies are being used to support health system needs. Historically, the diverse communities working in digital health—including government stakeholders, technologists, clinic...
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
